Home > Cashflow Statement > CONCORD DRUGS

CONCORD DRUGS
Cash Flow from Operating Activities

    Back to Cashflow Statement
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3.72 Cr₹0.79 Cr₹1.66 Cr₹0.77 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD DRUGS ?

The latest Cash Flow from Operating Activities ratio of CONCORD DRUGS is ₹3.72 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹3.72 Cr
Mar2024₹0.79 Cr
Mar2023₹1.66 Cr
Mar2022₹0.77 Cr

How is Cash Flow from Operating Activities of CONCORD DRUGS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹3.72 Cr
369.95
Mar2024 ₹0.79 Cr
-52.38
Mar2023 ₹1.66 Cr
114.86
Mar2022 ₹0.77 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹96.3 Cr 2.5% 2.2% 0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

2.5%

2.2%

0.6%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses